Male :

Female:
45 %
55%
 39yrs
5%
19yrs
29 yrs 15%
12.5%

22 yrs
28yrs 25%
27.5%

24 yrs
15 %
Gender related sensitivity distribution
 Gender * AMP Crosstabulation
Count
AMP Total
S R
Gender male 7 11 18
female 14 8 22
Total 21 19 40
AMPICILIN

S
14/22

R
11/18
R
S 8/22
7/18
 Gender * MERO Crosstabulation
Count
MERO Total
S R
Gender male 11 7 18
female 13 9 22
Total 24 16 40
MEROPENEM

S
13/22
S
11/18
R R
7/18 9/22
Gender * CN Crosstabulation
Count
CN Total
S R
Gender male 8 10 18
female 15 7 22
Total 23 17 40
CEPHALEXIN

S
15/22

R
S 10/18
8/18 R
7/22
 Gender * AK Crosstabulation
Count
AK Total
S R
Gender male 11 7 18
female 17 5 22
Total 28 12 40
AMIKACIN

Your text here

S
17/22

S
11/18

R
7/18 R
5/22
 Gender * SCF Crosstabulation
Count
SCF Total
S R
Gender male 7 11 18
female 12 10 22
Total 19 21 40
 S
12/22
R
11/18
R
10/22
S
7/18
 Gender * IMP Crosstabulation
Count
IMP Total
S R
Gender male 13 5 18
female 14 8 22
Total 27 13 40
IMIPENEM

S S
13/18 14/22

R
8/22
R
5/18
 Gender * C Crosstabulation
Count
C Total
S R
Gender male 10 8 18
female 15 7 22
Total 25 15 40
CHLORAMPHENICOL

S
15/22
S
10/18

R
R 7/22
8/18
 Gender * FEP Crosstabulation
Count
FEP Total
S R
Gender male 11 7 18
female 11 11 22
Total 22 18 40
 S
11/22
S
11/18

R
R 11/22
7/18
 Gender * CRO Crosstabulation
Count
CRO Total
S R
Gender male 12 6 18
female 11 11 22
Total 23 17 40
CEFTRIAXONE

R
11/22
S S
12/18 11/22

R
6/18
 Gender * LEV Crosstabulation
Count
LEV Total
S R
Gender male 13 5 18
female 13 9 22
Total 26 14 40
LEVOFLOXACIN

S
13/18 S
13/22

R
9/22
R
5/18
Gender * CIP Crosstabulation
Count
CIP Total
S R
Gender male 10 7 17
female 16 6 22
Total 26 13 39
CIPROFLOXACIN

S
16/22

S
10/17
R
R 6/22
7/17
Gender * SXT Crosstabulation

Count
SXT Total
S R
Gender male 7 11 18
female 8 14 22
Total 15 25 40
SULFAMETHOXAZOLE

R
14/22

R
11/18

S S
7/18 8/22
Gender * FOS Crosstabulation

Count
FOS Total
S R
Gender male 15 3 18
female 14 8 22
Total 29 11 40
FOSFOMYCIN

S S
15/18 14/22

R
8/22
R
3/18
Gender * TZP Crosstabulation

Count
TZP Total
S R
Gender male 12 6 18
female 14 8 22
Total 26 14 40
TAZOBACTAM

S
S 14/22
12/18

R
R
8/22
6/18
Gender * Nit Crosstabulation
Count
Nit Total
S R
Gender male 13 3 16
female 10 10 20
Total 23 13 36
NITROFURANTION

S R
13/16 10/20

S
10/20

R
3/16
Age related sensitivity pattern